IPProton (Omeprazole): 20 years of innovation and leadership in the treatment of digestive pathologies

For two decades, IPProton, the famous proton pump inhibitor developed by MédiS laboratories, has been celebrating its twentieth anniversary.

This drug has not only revolutionized the treatment of digestive diseases in Tunisia but continues to significantly improve the quality of life of patients.

A look back at an exemplary journey and the major advances that have marked its history.

A noble mission: Improving the quality of life of patients

Since its introduction to the market, IPProton has made it its mission to improve the quality of life of people suffering from digestive pathologies. This mission was achieved through the launch of innovative therapeutic solutions adapted to the specific needs of patients.

Innovation from the start : The freeze-dried form

One of the first notable innovations was the launch of the freeze-dried form of Omeprazole. This formulation allowed better conservation of the active ingredient, thus offering a practical and effective alternative to existing treatments, and strengthening our pioneering position on the Tunisian market.

First Marketing Authorization in May 2003

In May 2003, IPProton reached a key milestone with obtaining the first Marketing Authorization (MA) for injectable Omeprazole. This advance has made it possible to offer a new therapeutic option for urgent and severe cases, thus meeting a crucial need for healthcare professionals and their patients.

Range expansion: Comprehensive coverage strategy

The range then expanded with the introduction of capsules in boxes of 8, 16, and 28 units. This strategic choice made it possible to cover all digestive pathologies, ensuring availability adapted to each treatment and each patient, further consolidating our leadership in the market.

Leadership through effective market strategy

IPProton's three presentations gave our product a significant advantage in the market. This positioning resulted in obtaining the status of leader, characterized by the largest market share (PDM) in Tunisia in a Hypercompetitive market.

Expertise and quality: The foundation of our success

The expertise of our team combined with the superior quality of our manufacturing has been essential in establishing and maintaining strong and lasting relationships with healthcare professionals. These relationships are based on trust and the sharing of a common goal: the well-being of patients.

Experience shared with healthcare professionals

Doctors and pharmacists have witnessed the benefits provided by IPProton, observing the improvement in the condition of their patients on a daily basis. This shared experience has strengthened our product's reputation as a trusted solution for the treatment of digestive disorders.

Operational synergy: A pillar of our success

The synergy between our production site and operations management has played a crucial role in our ability to innovate and respond effectively to market demands. This coordination has enabled continuous improvement of our processes and our offer.

MédiS in the service of health

In conclusion, MédiS remains faithful to its commitment: to serve health.